Opens Path to Accessible Cell Therapies Through Increased Throughput and Decreased Manufacturing Costs PARIS, Jan. 9, 2025 /PRNewswire/ — Astraveus SAS (“Astraveus” or the “Company”), the Benchtop Cell Factory company, today announces the first ever successful end-to-end production of…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.